Medicure Announces Completion of Enrollment in Its MEND-PNPO Phase 3 Clinical Trial

WINNIPEG, MB / / September 28, 2026 / Medicure Inc. ("Medicure" or the "Company") TSXV:MPHOTC:MCUJF, a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, today announced the co…